Associations of 1- and 3-methylhistidine with long-term risk of acute myocardial infarction and mortality

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Espen Ogland Bjornestad

Stavanger University Hospital, Stavanger (Norway)

7 More presentations in this session

Presentation thumbnail

Role of subclinical primary aldosteronism in valvular and vascular calcification: a population-based cohort study

Mr A. Angelico-Goncalves (Vila Nova de Gaia, PT)

Abstract Slides

Presentation thumbnail

High levels of small dense LDL cholesterol potentiate the risk of poor glycemic management for long-term prognosis in patients with stable coronary artery disease

Professor S. Koba (Tokyo, JP)

Abstract Slides

Presentation thumbnail

High-sensitivity C-reactive protein as a predictor of cardiovascular events in young patients following myocardial infarction

Doctor F. Sousa (Funchal, PT)

Abstract Slides

Presentation thumbnail

Incidence and risk factors of perioperative myocardial injury after non-cardiac surgery in JAPAN: a prospective observational multicenter cohort study

Professor K. Yamaura (Fukuoka, JP)

Abstract Slides

Presentation thumbnail

Lipidomic, plasma and flow cytometry signatures enhance the classification of patients with advanced CVD and CKM syndrome

Doctor J. Pinzon Cortes (Seattle, US)

Abstract Slides

Access the full session

Session thumbnail

Risk factors (7)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Presentation

Advancements and challenges in cardiovascular risk stratification: an overview of cardiac biomarkers

Webinar

Biomarkers of clinical utility in cardiovascular disease

Congress Session

Challenges and innovations in cardiovascular risk stratification with cardiac biomarkers

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources